Eli Bixby is co-founder and ML Lead of Cradle, the Protein Engineering Platform for biological innovation, with teams in Amsterdam, Zurich, and the United States. Scientists at many of the biggest names in global pharmaceutical, industrial bio, agriculture and consumer goods — including Novonesis, Bayer, and Novo — use Cradle to design and optimize proteins for therapeutics, food, materials, and diagnostics, across more than 80 active R&D programs. Cradle has raised more than $100M to date, including a $73M Series B led by IVP. In 2026, Bayer and Lundbeck both entered multi-year collaborations with Cradle.
Eli leads Cradle's machine learning research and engineering. Before Cradle, he worked at Google across the Brain, Accelerated Science, and Cloud teams, on biological sequence design, AutoML, and natural language understanding. He studied mathematics, computer science, and biochemistry, and speaks regularly at leading antibody engineering and AI conferences.